North America
In the North American region, the fourth quarter of 2022 saw altering market trends for Sulfamethoxazole Prices. Prices were expected to increase through the second month of the quarter starting with Q4 2022 because of the high cost of manufacturing, numerous logistical issues, and rising inflation. Rising transportation costs and congestion at the key ports also helped keep the market position strong. Due to easing inflation and lowering end-user sector demand, prices start to drop later in December. During the month of December, the settlement price of Sulfamethoxazole API came down to USD 19340/MT CFR Houston.

Asia
The fourth quarter of 2022 saw a range of sentiments on the Sulfamethoxazole API market. At the commencement of Q4 2022, the prices were recorded to increase till the second month of Q4 on the back of increasing demand from the end-user sector and several logistic issues. Also, the strict zero covid policies and repeated lockdowns in the Chinese provinces affected the market situation. The increased production cost on the back of rising energy prices and increased domestic manufacturing to cater to regional and international orders, kept the market tight. However, as domestic retailers had sufficient stock on hand later in the month of December, the cost of Sulfamethoxazole API decreased. The market remained poor due to negative consumer sentiment as well. During the month of December, the settlement price of Sulfamethoxazole API came down to USD 16120/MT FOB Shanghai.

Europe
Prices for Sulfamethoxazole API in the European region showed a see-saw tendency in the fourth quarter of 2022. The demand for Sulfamethoxazole API from the pharmaceutical industry was experienced to be steady. The supply chain was impacted by the continuous port congestion and supply disruption in the European region, which resulted in a rise in pricing in the first two months of Q4 2022. The elevated trajectory of Sulfamethoxazole API was also influenced by the high freight costs. Nevertheless, December sees a price decline as a result of rising stocks and declining end-user sector demand. During the month of December, the settlement price of Sulfamethoxazole API came down to USD 21020/MT CFR Hamburg.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.

https://www.chemanalyst.com/Pricing-data/sulfamethoxazole-1395